Neurology : Transcranial Magnetic Stimulation Distinguishes Alzheimer Disease From Frontotemporal Dementia is organized by American Academy of Neurology (AAN) and will be held during Aug 15, 2017 - Aug 15, 2020.
The target audience for this medical event is Neurologists. This CME Conference has been approved FOR a maximum of 0.75 AMA PRA Category 1 Credits.
Conference Objectives are :
Upon completion of the article by Benussi et al, the participant should be able to:
• Identify transcranial magnetic stimulation (TMS) paradigms shown in this study that can help differentiate between healthy controls and patients with Alzheimer disease (AD).
• Describe the diagnostic test characteristics in this study of several TMS paradigms regarding their ability to distinguish frontotemporal dementia (FTD) from AD.
• Discuss the ability of TMS to assist in the diagnosis of AD and FTD in patients with mild disease severity as demonstrated in this study.
Additional details will be posted as soon as they are available.